Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Low incidence of positive smooth muscle antibody and high incidence of isolated IgM elevation in Chinese patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a retrospective study

BMC Gastroenterology201212:1

DOI: 10.1186/1471-230X-12-1

Received: 20 August 2011

Accepted: 3 January 2012

Published: 3 January 2012

Abstract

Background

Up to now, few data are available regarding the clinical characteristics of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. The study was to investigate and analyze the prevalent and clinical features of Chinese patients with this disease.

Methods

Clinical data on patients diagnosed as autoimmune hepatitis and primary biliary cirrhosis overlap syndrome in our hospital from January 2001 to December 2006 were collected and analyzed.

Results

Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis accounted for 10.33% of patients with autoimmune liver diseases during the past six years. For these patients with overlap syndrome, xanthochromia, lethargy and anorexia were the predominant complaints; a low incidence (14/146) of smooth muscle antibody positivity and a high incidence (37/89) of isolated IgM elevation were the main serological characteristics.

Conclusions

Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis was not rare in Chinese patients with clinical manifests of autoimmune liver diseases. Overlap of the diseases should not be disregarded when isolated IgM elevation was exhibited, and smooth muscle antibody might have little diagnostic significance in the overlap syndrome. If it was difficult to make a definite diagnosis, liver biopsy was necessary.

Keywords

autoantibody overlap syndrome autoimmune hepatitis primary biliary cirrhosis

1. Background

Autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis (PSC) are three major clinicopathologic entities of autoimmune liver diseases. Besides, some patients with autoimmune liver disease present with characteristics of a second autoimmune liver disease (i.e. AIH and PBC overlapping). These cases have been defined as overlap syndrome. Patients with overlap syndrome usually present with nonspecific symptoms, including lethargy, arthralgias, and myalgias. A combination of clinical and laboratory or pathologic criteria is necessary for the diagnosis of the disease. In the laboratory test, autoantibodies are the serological hallmarks. Serum antinuclear antibody (ANA), smooth muscle antibody (SMA) and antimitochondrial antibody (AMA) are routinely detected in these patients [1].

Although combined features of both PBC and PSC have been reported in single cases, there is no clear evidence for the existence of an overlap of PBC and PSC [2]. The overlap syndrome of AIH and PBC is the most common form, and it shows a more progressive course towards liver cirrhosis and liver failure than AIH or PBC alone [35]. However, up to now, the pathogenesis of overlap syndrome is poorly understood [6], and few data are available regarding the clinical characteristics of this disease, and moreover, reports on the prevalent and serological features of this condition in Chinese population are still lacking. The aim of this retrospective study is to investigate and analyze the prevalent and clinical features of Chinese patients with AIH and PBC overlap syndrome.

2. Methods

2.1. Patients

Patients diagnosed as overlap syndrome of AIH and PBC in 302 hospital from January 2001 to December 2006 were included in the retrospective study. The diagnosis was based on the criteria established by Chazouillères O, et al [7]. Exclusion criteria included coinfection with hepatitis A, C, D, E, Epstein-Barr virus, cytomegalovirus or HIV; the presence of other forms of liver diseases such as alcoholic liver disease, drug hepatitis or Wilson's disease. 146 patients were eventually enrolled in our study. Informed written consent for the analysis was obtained from each patient. The study was approved by the ethics committee of Beijing 302 Hospital.

2.2. Serological markers and liver histopathology

Serum autoantibodies, including antinuclear antibody (ANA), smooth muscle antibody (SMA) and antimitochondrial antibody (AMA) were tested using indirect immunofluorescence with the standard methods (Euroimmun Medizinnische Labordiagnostika AG, Germany), and sera were considered to be positive when they produced a reaction at a dilution of ≥ 1:100. Immunoglobulin (Ig) assay were taken with the mothod of immunological turbidimetry (Diasys Diagnostic Systems, China). The normalized levels of IgG, IgM and IgA were respectively 7.23-16.6 g/L, 0.63-2.77 g/L and 0.69-3.82 g/L.

Biochemical profiles, including alanine transarninase (ALT), aspartate aminotransferase (AST), total bilirubin (TBil), gamma glutamyl transferase (GGT) and alkaline phosphatase (ALP) were measured using standard laboratory procedure. The normalized levels of ALT, AST, TBil, GGT and ALP were respectively < 40 U/L, < 40 U/L, < 17.1 umol/L, 7-32 U/L, and 40-150 U/L.

Liver biopsy was performed in some cases for definite diagnosis, and biopsy specimens were examined in the Pathology Department.

2.3. Statistical analysis

Data analysis were performed using SAS 9.2 software (SAS Institute Inc., Cary, NC, USA) and the quantitative data were expressed as mean and standard deviation.

3. Results

3.1. Baseline characteristics and prevalent features

In this six-year retrospective survey based on our hospital, a total of 1413 patients was diagnosed as autoimmune liver diseases, of which, 577 were AIH, 685 were PBC, 5 were PSC, 146 were overlap syndrome of AIH and PBC, and none were overlap syndrome of AIH and PSC. Overlap syndrome of AIH and PBC accounts for 10.33% of patients with autoimmune liver diseases, and this proportion was similar to that in previous reports in India and France [8, 9]. The characteristics of the 146 patients at the diagnosis of overlap syndrome of AIH and PBC were described in Table 1.
Table 1

Characteristics of patients at the diagnosis of AIH and PBC overlap syndrome

 

Value

sex: female/male

125/21

age (years)

46.50 ± 10.08

TBil (umol/L)

43.08 ± 27.94

ALT (U/L)

116.80 ± 37.10

AST (U/L)

77.02 ± 32.75

GGT (U/L)

369.12 ± 329.32

ALP (U/L)

399.40 ± 221.53

IgM

3.91 ± 2.08

IgG

18.79 ± 1.56

 

n = 146

ALT, alanine transarninase; AST, aspartate aminotransferase; TBil, total bilirubin; GGT, gamma glutamyl transferase; ALP, alkaline phosphatase; Ig, immunoglobulin.

3.2. Clinical features

We viewed the 146 case histories, and found that, as the chief complaints at the diagnosis, xanthochromia occurs in 86 patients, with the incidence of 58.90%; lethargy occurs in 79 patients, with the incidence of 54.11%; anorexia occurs in 75 patients, with the incidence of 51.37%; pruritus occurs in 51 patients, with the incidence of 34.93%; discomfort in hepatic region occurs in 33 patients, with the incidence of 22.60%; arthralgias or myalgias occurs in 33 patients, with the incidence of 22.60%; asymptomatic elevation of serum liver enzymes occurs in 20 patients, with the incidence of 13.70%; splenomegaly occurs in 12 patients, with the incidence of 8.22%. Details were summarized in Table 2.
Table 2

Chief complaints of patients at the diagnosis of AIH and PBC overlap syndrome

Chief complaint

Case

Incidence (%)

Xanthochromia

86

58.90

Lethargy

79

54.11

Anorexia

75

51.37

Pruritus

51

34.93

discomfort in hepatic region

33

22.60

arthralgias or myalgiasg

33

22.60

asymptomatic elevation of serum liver enzymes

20

13.70

splenomegaly

12

8.22

 

n = 146

 
Of the 146 patients, 140 had positive ANA, accounting for 95.89%; 129 had positive AMA, accounting for 88.36%; 14 had positive SMA, accounting for 9.59%. Details were seen in Table 3.
Table 3

Features of autoantibodies in patients

Features

No.

Incidence (%)

ANA positive

140

95.89

AMA positive

129

88.36

SMA positive

14

9.59

both ANA and AMA positive

122

83.56

both SMA and AMA positive

10

6.85

 

n = 146

 

ANA, antinuclear antibody; AMA, antimitochondrial antibody; SMA, smooth muscle antibody.

A total of 89 patients with immunoglobulin assay was identified. Of these patients, 37 had isolated IgM elevation, accounting for 41.57%; 17 had isolated IgG elevation, accounting for 19.10%; 23 had both IgM and IgG elevation, accounting for 25.84%; 12 had neither IgM nor IgG elevation, accounting for 13.48%. The results were summarized in Table 4.
Table 4

Features of immunoglobulin (Ig) elevation in patients

Features

No.

Percentage (%)

isolated IgM elevation

37

41.57

isolated IgG elevation

17

19.10

both IgM and IgG elevation

23

25.84

neither IgM nor IgG elevation

12

13.48

Total

89

100.00

58 patients underwent liver biopsy. Diagnostic pathological changes, including bile duct lesion, interface hepatitis and plasma cell infiltration were observed in all patients. Summarization of the pathological features for these patients was seen in Yanling Sun's previous study [10]. Pathological changes in a patient with AIH and PBC overlap syndrome were shown in Figure 1.
https://static-content.springer.com/image/art%3A10.1186%2F1471-230X-12-1/MediaObjects/12876_2011_Article_670_Fig1_HTML.jpg
Figure 1

Typical pathological changes (bile duct lesion, interface hepatitis and plasma cell infiltration) in a Chinese patient diagnosed as AIH and PBC overlap syndrome. (HE, ×200).

4. Discussion

The worldwide prevalence of overlap syndrome of AIH and PBC is unknown. The first cases of this disease were reported almost 30 years ago, and this entity was assumed to be rare [11]. However, in our hospital, 10.33% of patients with autoimmune liver diseases were diagnosed as overlap syndrome of AIH and PBC based on the clinical manifests, laboratory test, and liver biopsy during the six years. Our study also showed that, similar to other studies [12, 13], overlap syndrome of AIH and PBC was more common in female patients, with a female:male ratio of roughly 6:1. However, the median age of patients with overlap syndrome was older than that of a previous report about European patients [9].

Presentation of autoimmune liver diseases varies widely, ranging from asymptomatic elevations of serum liver enzymes to massive hepatic necrosis resulting in fulminant hepatic failure, and there are no disease-specific clinical features. Günsar F, et al [14] reported that, lethargy was the most common symptom in these patients. Our study showed that xanthochromia, lethargy and anorexia were the predominant three chief complaints, that was, besides lethargy, xanthochromia was also a most common symptom in Chinese patients with overlap syndrome of AIH and PBC.

Serum autoantibodies have steadily established themselves as critical biomarkers for the diagnosis of autoimmune diseases [15]. For the North-American and European population, ANA and SMA constitute the standard repertoire for the diagnosis of autoimmune hepatitis, and AMA is the diagnostic marker of primary biliary cirrhosis [7, 16]. In our study, the majority of patients had positive serum ANA (140/146) and AMA (129/146), whereas only minor patients (14/146) had positive serum SMA. This result showed that, there was a low incidence of positive serum SMA in Chinese patients with overlap syndrome of AIH and PBC, which might indicate that serum SMA may have little diagnostic significance in the overlap syndrome for Chinese patients. This finding agreed with another investigation performed by Zhenxia Liu [17].

Some studies had shown that the serum immunoglobulins could elevate in most cases of autoimmune liver diseases [1822] and types of the elevated immunoglobulins were distinctive in different categories of autoimmune liver diseases. IgG was the predominant immunoglobulin elevated in serum of AIH patients while IgM was elevated in most patients with PBC [2325]. However, in our study, isolated IgM elevation was preponderant (37/89), which presented with features of PBC. Previously, a German study showed that patients with overlap syndrome of AIH and PBC presented with typical features of PBC when compared to AIH and PBC patients [13]. The reason, we inferred, might be that serological markers were often featured with one predominant pathological change to the other in overlap syndrome. But how to distinguish the predominant one needed further studies.

5. Conclusion

Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis was not rare in Chinese patients with clinical manifests of autoimmune liver diseases. Overlap of the diseases should not be disregarded when isolated IgM elevation was exhibited, and smooth muscle antibody might have little diagnostic significance in the overlap syndrome. If it was difficult to make a definite diagnosis, liver biopsy was necessary.

List of abbreviations

AIH: 

autoimmune hepatitis

ALP: 

alkaline phosphatase

ALT: 

alanine transarninase

AMA: 

antimitochondrial antibody

ANA: 

antinuclear antibody

AST: 

aspartate aminotransferase

GGT: 

gamma glutamyl transferase

PBC: 

primary biliary cirrhosis

PSC: 

primary sclerosing cholangitis

SMA: 

antismooth muscle antibody

Tbil: 

total bilirubin.

Declarations

Acknowledgements and Funding

We are grateful to Yanling Sun for her assistance in supplying the pathological picture.

No funding was provided to this study.

Authors’ Affiliations

(1)
Liver Failure Therapy and Research Center
(2)
Case-history Office

References

  1. Björnsson E, Talwalkar J, Treeprasertsuk S, Neuhauser M, Lindor K: Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol. 2011, 9 (1): 57-63. 10.1016/j.cgh.2010.07.016.View ArticlePubMedGoogle Scholar
  2. Rust C, Beuers U: Overlap syndromes among autoimmune liver diseases. World J Gastroenterol. 2008, 14 (21): 3368-3373. 10.3748/wjg.14.3368.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Hirschfield GM, Al-Harthi N, Heathcote EJ: Current status of therapy in autoimmune liver disease. Therap Adv Gastroenterol. 2009, 2 (1): 11-28. 10.1177/1756283X08098966.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Coss Adame E, Granados J, Uribe M, Torre A: Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1?. Ann Hepatol. 2011, 10 (1): 28-32.PubMedGoogle Scholar
  5. Cooper GS, Bynum ML, Somers EC: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun. 2009, 33 (3-4): 197-207. 10.1016/j.jaut.2009.09.008.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Czaja AJ: Autoantibodies as prognostic markers in autoimmune liver disease. Dig Dis Sci. 2010, 55: 2144-2161. 10.1007/s10620-010-1268-4.View ArticlePubMedGoogle Scholar
  7. Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998, 28 (2): 296-301. 10.1002/hep.510280203.View ArticlePubMedGoogle Scholar
  8. Arulprakash S, Sasi AD, Bala MR, Pugazhendhi T, Kumar SJ: Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis. J Assoc Physicians India. 2010, 58: 455-456.PubMedGoogle Scholar
  9. Heurgué A, Vitry F, Diebold MD, Yaziji N, Bernard-Chabert B, Pennaforte JL, Picot R, Louvet H, Frémond L, Geoffroy P, Schmit JL, Cadiot G, Thiéfin G: Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterol Clin Biol. 2007, 31 (1): 17-25. 10.1016/S0399-8320(07)89323-7.View ArticlePubMedGoogle Scholar
  10. Sun YL, Zhao JM, Meng X, Li WS: Clinical and pathological studies on the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. Med J Chin PLA. 2006, 31 (7): 662-665. (in Chinese)Google Scholar
  11. Beuers U: Hepatic overlap syndromes. J Hepatol. 2005, 42: S93-S99. 10.1016/j.jhep.2004.11.009.View ArticlePubMedGoogle Scholar
  12. Czaja AJ: Autoimmune liver disease. Curr Opin Gastroenterol. 2008, 24 (3): 298-305. 10.1097/MOG.0b013e3282f57268.View ArticlePubMedGoogle Scholar
  13. Lohse AW, zum Büschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP: Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology. 1999, 29 (4): 1078-1084. 10.1002/hep.510290409.View ArticlePubMedGoogle Scholar
  14. Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y: Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Hepatogastroenterology. 2002, 49 (47): 1195-1200.PubMedGoogle Scholar
  15. Selmi C, Gershwin ME: Autoantibodies in autoimmune liver disease: biomarkers versus epiphenomena. Gut. 2010, 59 (6): 712-713. 10.1136/gut.2009.203091.View ArticlePubMedGoogle Scholar
  16. Neuhauser M, Bjornsson E, Treeprasertsuk S, Enders F, Silveira M, Talwalkar J, Lindor K: Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis. Am J Gastroenterol. 2010, 105 (2): 345-353. 10.1038/ajg.2009.616.View ArticlePubMedGoogle Scholar
  17. Liu ZX, Liu Y, Huang XJ, Liu YL: Clinical studies on AIH, PBC and AIH-PBC overlap syndrome. Hebei Med J. 2011, 33 (1): 49-50. (in Chinese)Google Scholar
  18. Teufel A, Weinmann A, Kahaly GJ, Centner C, Piendl A, Wörns M, Lohse AW, Galle PR, Kanzler S: Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol. 2010, 44 (3): 208-213. 10.1097/MCG.0b013e3181c74e0d.View ArticlePubMedGoogle Scholar
  19. Jalihal A, Telisinghe PU, Chong VH: Profiles of autoimmune hepatitis in Brunei Darussalam. Hepatobiliary Pancreat Dis Int. 2009, 8 (6): 602-607.PubMedGoogle Scholar
  20. Moreira RK, Revetta F, Koehler E, Washington MK: Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease. World J Gastroenterol. 2010, 16 (4): 453-7. 10.3748/wjg.v16.i4.453.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Kawa S, Kitahara K, Hamano H, Ozaki Y, Arakura N, Yoshizawa K, Umemura T, Ota M, Mizoguchi S, Shimozuru Y, Bahram S: A novel immunoglobulin-immunoglobulin interaction in autoimmunity. PLoS One. 2008, 3 (2): e1637-10.1371/journal.pone.0001637.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Washington MK: Autoimmune liver disease: overlap and outliers. Mod Pathol. 2007, 20 (Suppl 1): S15-S30.View ArticlePubMedGoogle Scholar
  23. Cabibi D, Tarantino G, Barbaria F, Campione M, Craxì A, Di Marco V: Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Dig Liver Dis. 2010, 42 (8): 585-592. 10.1016/j.dld.2009.12.006.View ArticlePubMedGoogle Scholar
  24. Lee H, Stapp RT, Ormsby AH, Shah VV: The usefulness of IgG and IgM immunostaining of periportal inflammatory cells (plasma cells and lymphocytes) for the distinction of autoimmune hepatitis and primary biliary cirrhosis and their staining pattern in autoimmune hepatitis-primary biliary cirrhosis overlap syndrome. Am J Clin Pathol. 2010, 133 (3): 430-437. 10.1309/AJCPE93GZSHUNTAI.View ArticlePubMedGoogle Scholar
  25. Krawitt EL: Discrimination of autoimmune hepatitis: autoantibody typing and beyond. J Gastroenterol. 2011, 46 (Suppl 1): 39-41.View ArticlePubMedGoogle Scholar
  26. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/12/1/prepub

Copyright

© Zhao and Han; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.